蠲痹颗粒醇提物调控MAPK信号转导抑制T细胞活化效应机制的研究*
作者:
作者单位:

(云南中医药大学,云南 昆明 650500)

作者简介:

通讯作者:

中图分类号:

R285.5

基金项目:

收稿日期: 2022 - 02- 10
基金项目: 国家中医药管理局国家中医(类风湿关节炎)临床研究基地建设项目(国中医药科技函[2018]131号);云南省中医(风湿病)临床医学研究中心项目(202102AA310006);云南省卫生科技计划项目(2017NS166)
第一作者简介: 邹楠婷(1999-),女,在读硕士研究生,研究方向:免疫药理学。
通信作者: 彭江云,E-mail: pengjiangyun@126.com;万春平,E-mail: wanchunping1012@163.com


Mechanism of Juanbi Granules Ethanol Extract Suppressing the Activation of T Cells through the MAPK Signaling Transduction Pathway
Author:
Affiliation:

(Yunnan University of Chinese Medicine, Kunming 650500, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的 探讨蠲痹颗粒醇提物(JBKL)在丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)信号转导通路中抑制T细胞活化的效应机制,揭示扶阳学派应用扶阳理论治疗类风湿关节炎(rheumatoid arthritis,RA)的现代免疫学机制。方法 噻唑蓝(MTT)比色法检测JBKL对伴刀豆球蛋白(Con A)、脂多糖(LPS)诱导T、B脾淋巴细胞增殖活性及细胞毒性的影响;建立体外抗CD3单克隆抗体(Anti-CD3 mAb)诱导的T细胞活化模型,MTT检测JBKL对T细胞体外活化增殖的影响,酶联免疫吸附法(ELISA)测定干扰素-γ(IFN-γ)、白细胞介素-17A(IL-17A)、IL-10和IL-6在细胞上清中的含量;蛋白质印迹法(Western blot)检测体外纯化CD4+ T细胞中ERK和p38蛋白的磷酸化水平。结果 JBKL在浓度30 μg/mL时显著抑制Con A、Anti-CD3 mAb和LPS诱导的T细胞和B细胞增殖功能;JBKL在浓度(3~30) μg/mL时对正常脾淋巴细胞无明显的细胞毒性作用,明显下调IFN-γ、IL-17A和促炎因子IL-6的含量,而促进IL-10的分泌;JBKL在浓度100 μg/mL时抑制MAPK信号通路,可降低纯化CD4+ T细胞磷酸化ERK和p38蛋白的表达。结论 JBKL阻碍T细胞介导的免疫反应,减少MAPK信号通路磷酸化ERK和p38蛋白表达,可能是其治疗RA的重要分子机制之一。

    Abstract:

    Objective To investigate the potential mechanism of the ethanol extract of Juanbi Granules (JBKL) on T cell activation via the mitogen-activated protein kinase (MAPK) signaling transduction pathway, and to reveal the mechanism of immunosuppression on the application of Yang-aided theory in rheumatoid arthritis(RA) treatment. Methods T cells and B cells proliferation assay were induced by concanavalin A(Con A) and lipopolysaccharide(LPS), respectively. Splenocyte proliferation and cytotoxicity were detected by MTT assay. The T cells were further stimulated in vitro with Anti-CD3 mAb to establish Anti-CD3 mAb-induced T cells activation; ELISA assay was used to measure the supernatant concentrations of interferon-γ (IFN-γ), interleukin (IL)-17A, IL-10 and IL-6. The expression of MAPK signaling pathway related proteins (p-ERK and p-p38) in purified CD4+ T cells were detected by Western blot assay. Results Compared with the vehicle control group, JBKL (30 μg/mL) significantly inhibited the proliferation of T cells induced by Con A and Anti-CD3 mAb, and the proliferation of B cells responded to LPS. Further, JBKL groups had no remarkable cytotoxicity in normal mouse spleen lymphocytes. The levels of IFN-γ L-17A, IL-6 content were obviously decreased in the JBKL(3~30 μg/mL) group and the IL-10 content was up-regulated. The phosphorylation levels of ERK and p38 proteins were lower in the JBKL(100 μg/mL) group than those in the vehicle group. Conclusion JBKL can significantly restrain the activation and proliferation of CD4+ T cells, which may be related to the inhibition of p-ERK and p-p38 MAPK signaling pathways. This may be an important molecular mechanism contributes to the effect of JBKL in rheumatoid arthritis treatment.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭